UNSPSC 51331603: Pentiapine

This classification denotes a dopamine antagonist with the molecular formula C15H17N5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z5P36MQ43L, chemically known as 5-(4-methyl-1-piperazinyl)imidazo(2,1-b)(1,3,5)benzothiadiazepine maleate (1:1) but generally known as pentiapine, which bears US NIH Compound Identifier 54742. Most nations schedule pentiapine under HS 29349990 and SITC 51579. As of Q4 2014, PENTIAPINE remains the US FDA Preferred Term for this commodity. SMILES: CN1CCN(CC1)C2=NC3=CC=CC=C3SC4=NC=CN24.

UNSPSC 51331603 Pentiapine (Commodity) does not align with the recent state and local procurement activity recorded under this code. The three most recent opportunities tagged to the code cover naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer pharmacy benefit programs (Texas Health and Human Services Commission), and generic multi-source pharmaceuticals and over-the-counter products through a multistate cooperative purchasing vehicle (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations reference pentiapine or products within its pharmaceutical scope. The mismatch suggests either a coding error in the state and local procurement database or that this Commodity code sees no relevant recent activity.

If state and local procurement offices are using 51331603 for pharmaceutical procurement at all, the pattern reflects a broader trend toward bulk purchases of standard pharmaceutical products and drug-related public health commodities through competitive bidding (IFB), requests for proposal (RFP), and cooperative purchasing agreements. Issuing bodies include county health departments, state health and human services agencies, and multistate cooperative purchasing alliances that serve participating state and local government members across multiple jurisdictions. Recent opportunities span Florida, Texas, and Minnesota, with the cooperative purchasing mechanism extending to Oregon. Without recent opportunities clearly aligned to pentiapine itself, this code warrants close attention to whether it is being retired, reassigned, or simply dormant in current state and local procurement activity.